Ellis J C, Ahmad S, Molyneux E M
Department of Paediatrics, College of Medicine, University of Malawi, Blantyre, Malawi.
Arch Dis Child. 2005 Dec;90(12):1297-9. doi: 10.1136/adc.2005.080432. Epub 2005 Sep 20.
To improve the care of children who are victims of child sexual abuse (CSA) by routinely assessing eligibility for HIV post-exposure prophylaxis (PEP) and to investigate the feasibility, safety, and efficacy of such treatment started in a paediatric emergency department in Malawi.
Children presenting to the Queen Elizabeth Central Hospital, Blantyre between 1 January 2004 and 31 December 2004 with a history of alleged CSA were assessed for eligibility for HIV PEP and followed prospectively for six months.
A total of 64 children presented with a history of alleged CSA in the 12 month period; 17 were offered PEP. The remainder were not offered PEP because of absence of physical signs of abuse (n = 20), delay in presentation beyond 72 hours from assault (n = 11), repeated sexual abuse in the preceding six months (n = 15), and HIV infection found on initial testing (n = 1). No family refused an HIV test. No side effects due to antiretroviral therapy were reported. Of the 17 children commenced on PEP, 11 returned for review after one month, seven returned at three months, and two of 15 returned at six months post-assault. None have seroconverted.
In a resource-poor setting with a high HIV prevalence, HIV PEP following CSA is acceptable, safe, and feasible. HIV PEP should be incorporated in to national guidelines in countries with a high community prevalence of HIV infection.
通过常规评估暴露后预防艾滋病病毒(HIV)治疗(PEP)的适用性,改善遭受儿童性虐待(CSA)儿童的护理,并调查在马拉维一家儿科急诊科开始这种治疗的可行性、安全性和有效性。
对2004年1月1日至2004年12月31日期间到布兰太尔伊丽莎白女王中央医院就诊、有CSA指控史的儿童进行HIV PEP适用性评估,并进行为期6个月的前瞻性随访。
在这12个月期间,共有64名儿童有CSA指控史;17名儿童接受了PEP治疗。其余儿童未接受PEP治疗,原因包括无虐待身体迹象(n = 20)、袭击后超过72小时才就诊(n = 11)、在过去6个月内遭受多次性虐待(n = 15)以及初次检测发现HIV感染(n = 1)。没有家庭拒绝进行HIV检测。未报告抗逆转录病毒治疗的副作用。在开始接受PEP治疗的17名儿童中,11名在1个月后回来复诊,7名在3个月后回来复诊,15名中有2名在袭击后6个月回来复诊。没有人血清转化。
在HIV感染率高的资源匮乏地区,CSA后进行HIV PEP是可接受的、安全的和可行的。在社区HIV感染率高的国家,HIV PEP应纳入国家指南。